The table below shows ANI PHARMACEUTICALS INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
-
-
Cost of revenue
-
-
-
-
-
$87.16M
Gross profit
-
-
-
-
-
-
R&D
$51.66M
$44.58M
$34.29M
$22.32M
$11.37M
$16.00M
SG&A
$317.75M
ANIP annual revenue (10-K history)
ANI PHARMACEUTICALS INC reported annual revenue of $883.37M for fiscal year 2025. That is up 43.8% from $614.38M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $128.62M (FY 2016) to $883.37M. Figures come from the company's audited annual reports as filed with the SEC.